Artificial Intelligence for Diagnosing Periodontitis and Monitoring Gingival Inflammation

Evaluation of Artificial Intelligence Models for Periodontitis Diagnosis and Gingival Inflammation Monitoring at Tooth and Patient Levels: A Diagnostic Accuracy Study

Background and Objective:

Periodontitis and gingivitis are highly prevalent oral diseases that require accurate diagnostic classification and continuous gingival health monitoring. This study aims to develop, internally validate, and externally evaluate the diagnostic accuracy of artificial intelligence (AI) models for periodontitis staging and gingival inflammation assessment at both tooth and patient levels.

Study Design:

This is a multi-center observational study utilizing a large-scale primary clinical dataset for model development. To rigorously evaluate the generalizability of the trained AI models, two distinct pathways of independent external validation will be implemented across multiple clinical sites.

Research Phases & Validation Architecture:

Phase 1 (Periodontitis Diagnosis via Probing): Development of an AI model to diagnose periodontitis (binary classification: stage 0/I vs. stage II/III/IV) at both tooth and patient levels, using comprehensive clinical periodontal probing as the gold standard. External Validation I will be performed using an independent cohort from another campus of the primary hospital to test the model's diagnostic accuracy.

Phase 2 (Periodontitis Diagnosis via Radiographs): Development of an AI model to diagnose periodontitis (binary classification: stage 0/I vs. stage II/III/IV) at both tooth and patient levels, using digital panoramic radiographs as the reference standard. External Validation II will be conducted using distinct, independent image datasets acquired from two separate regional hospitals to evaluate geographic generalizability.

Phase 3 (Gingival Inflammation Monitoring): Development of an AI model to monitor and assess gingival inflammation at both tooth and patient levels, based on Probing Depth (PD) and Bleeding on Probing (BOP) as the gold standard. This model's performance will also be evaluated through External Validation I using the independent dataset from the primary hospital's alternative campus.

Significance:

By validating the AI models across varied institutional workflows and imaging systems, this study will provide high-level evidence on the clinical utility and robustness of AI-driven digital systems for automated periodontal screening and long-term health monitoring.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

900

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Shanghai, China
        • Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population consists of adult patients who sought routine dental care or periodontal evaluation at the primary medical center (including its main campus and an alternative secondary campus) and two independent regional hospitals. This multi-center population reflects a real-world, diverse clinical screening pool of patients presenting with varying degrees of periodontal health, ranging from completely healthy gingiva to severe, advanced periodontitis. Eligible participants are identified based on the availability of concurrent full-mouth clinical periodontal charting and digital panoramic radiographs.

Description

Inclusion Criteria:

  1. Patients aged > 18 years at the time of their clinical periodontal examination.
  2. Availability of complete full-mouth periodontal charting records, which must include Probing Depth (PD) and Bleeding on Probing (BOP) documented at 6 sites per tooth.
  3. Availability of a digital panoramic radiograph of acceptable diagnostic quality, taken within one months of the clinical periodontal examination.

Exclusion Criteria:

  1. Patients who are completely edentulous or those who have undergone full-arch dental implant rehabilitation (not applicable for natural teeth periodontitis staging).
  2. Panoramic radiographs with severe image degradation, including major motion artifacts, severe positioning errors, or poor contrast/exposure that obscures the alveolar bone crest.
  3. Presence of extensive metal artifacts or massive bilateral multiple fixed crowns/bridges that completely shadow the marginal bone level of interest.
  4. Incomplete clinical electronic medical records or missing core diagnostic descriptors required to establish the clinical gold standard for periodontitis staging or gingival inflammation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Multi-center Periodontal AI Development and Validation Cohort

Development Dataset (Primary Campus): Large-scale data used for the initial training and internal validation of the AI algorithms.

External Validation Dataset I (Secondary Campus): An independent dataset from an alternative campus of the primary hospital, used to validate clinical probing-based periodontitis diagnosis (Phase 1) and gingival inflammation monitoring (Phase 3).

External Validation Dataset II (Two Regional Hospitals): Separate imaging datasets from two distinct regional medical centers, used to validate radiograph-based periodontitis diagnosis (Phase 2).

The intervention evaluated in this observational study is the deployment of deep learning/artificial intelligence (AI) software models.

The AI algorithms process two streams of standard clinical data to perform three automated diagnostic tasks without altering patient care:

Automated classification of periodontitis stages (Stage 0/I vs. Stage II/III/IV) utilizing full-mouth clinical charting metrics.

Automated classification of periodontitis stages (Stage 0/I vs. Stage II/III/IV) utilizing digital panoramic radiographs.

Automated assessment and monitoring of gingival inflammation flags based on Probing Depth (PD) and Bleeding on Probing (BOP) patterns.

The outputs of these AI models will be directly compared against clinical and radiographic gold standards to calculate diagnostic accuracy metrics.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic Accuracy of the AI Model for Probing-Based Periodontitis Staging
Time Frame: Baseline (At a single point in time for each participant (cross-sectional assessment))
The diagnostic performance of the deep learning AI model in classifying periodontitis stages (binary classification: Stage 0/I vs. Stage II/III/IV) at both individual tooth and patient levels, using comprehensive clinical periodontal probing as the gold standard. Performance will be evaluated using the internal development dataset and verified using External Validation Dataset I (secondary campus data). Metrics will include Area Under the Receiver Operating Characteristic curve (AUC), Sensitivity, Specificity, and F1-score.
Baseline (At a single point in time for each participant (cross-sectional assessment))
Diagnostic Accuracy of the AI Model for Radiograph-Based Periodontitis Staging
Time Frame: Baseline (At a single point in time for each participant (cross-sectional assessment))
The diagnostic performance of the deep learning AI model in classifying periodontitis stages (binary classification: Stage 0/I vs. Stage II/III/IV) at both individual tooth and patient levels, using digital panoramic radiographs as the reference standard. Performance will be evaluated using the internal development dataset and verified using External Validation Dataset II (multi-center data from two separate regional hospitals). Metrics will include Area Under the Receiver Operating Characteristic curve (AUC), Sensitivity, Specificity, and F1-score.
Baseline (At a single point in time for each participant (cross-sectional assessment))
Diagnostic Accuracy of the AI Model for Gingival Inflammation Monitoring
Time Frame: Baseline (At a single point in time for each participant (cross-sectional assessment))
The performance of the deep learning AI model in detecting and monitoring gingival inflammation flags at both individual tooth and patient levels, using Probing Depth (PD) and Bleeding on Probing (BOP) metrics as the clinical gold standard. Performance will be evaluated using the internal development dataset and verified using External Validation Dataset I (secondary campus data). Metrics will include Sensitivity, Specificity, Positive Predictive Value (PPV), and Negative Predictive Value (NPV).
Baseline (At a single point in time for each participant (cross-sectional assessment))

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2025

Primary Completion (Actual)

March 10, 2026

Study Completion (Estimated)

September 10, 2026

Study Registration Dates

First Submitted

June 1, 2026

First Submitted That Met QC Criteria

June 4, 2026

First Posted (Actual)

June 5, 2026

Study Record Updates

Last Update Posted (Actual)

June 5, 2026

Last Update Submitted That Met QC Criteria

June 4, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • SH9H-2025-T196-4

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontal Disease

Clinical Trials on AI-driven Periodontal Diagnostic and Monitoring Algorithms

Subscribe